We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Improving the Speed and Cost-Efficiency of Drug Discovery

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Optibrium announced a collaboration with MolPort to offer StarDrop™ users fully integrated access to MolPort’s drug discovery database, which consists of 6.3 million commercially available screening compounds and chemical building blocks via its curated collection of catalogues from major chemical suppliers. The latest in a series of recent partnerships with commercial providers, this link with MolPort further extends StarDrop’s capabilities to improve the speed, efficiency, and productivity of the drug discovery process. 

MolPort specialises in the sourcing, and effective single supplier access, of chemicals for drug discovery. From a collection of curated catalogues from all major suppliers, MolPort has created a marketplace and order fulfilment platform for commercially available chemistries which includes 6.7 million high-throughput screening (HTS) compounds. 

StarDrop users can access the MolPort database to quickly search for commercially available screening compounds and reagents. The free link enables users to not only look for exact chemical matches but also select compounds based on similarity to the chemistry of interest.  This provides an invaluable tool for chemists to easily enrich their understanding of structure–activity relationships (SAR) in a project’s chemistry. MolPort’s compound search results are presented directly in StarDrop, where its unique capabilities for analysis of SAR and compound optimisation guide the selection of compounds with an improved chance of success.

Dr Matthew Segall, CEO of Optibrium, commented: “We are pleased to be working with MolPort in our latest collaboration with leading providers in drug discovery and wider chemistry fields. MolPort specialises in sourcing large numbers of chemicals from an array of large and the more niche suppliers and StarDrop users can now benefit from seamless access to some 6.3 million screening compounds and building blocks.”

Dr Imants Zudans, CEO of MolPort said: “Over 85% of product inventory listed in the MolPort database is synchronised daily with suppliers. StarDrop users gain direct access to these up-to-date data and can have a very high degree of confidence that all samples can be ordered immediately from MolPort, reducing design-test cycle times.”

Source:

Story from Optbrium. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.